Pseudotyped lentiviral particles expressing SARS-CoV-2 Spike protein were produced and titered as previously described (Crawford et al., 2020). HEK293T cells were seeded at a density of 5 × 105 cells per well in 6-well plates containing DMEM (supplemented with 10% fetal bovine serum, 2 mM L-glutamine, and penicillin/streptomycin/fungizone). After incubating for 16-25 hours, cells were transfected using FuGENE-6 (Promega) with the Luciferase_IRES_ZsGreen backbone, the Gag/Pol-, Rev-, and Tat lentiviral helper plasmids, and a plasmid containing the codon-optimized Spike sequence from the Wuhan-Hu-1 strain. The Spike sequence contained a 21 amino acid deletion at the cytoplasmic tail (also known as HDM_Spikedelta21). After incubating for 24 hours, we replaced media with fresh supplemented DMEM. Between 50-60 hours post-transfection, viral supernatants were collected, filtered through a 0.22 m Steriflip filter and stored at −80°C. To titer pseudovirus, 1.25 × 104 HEK293T cells expressing ACE2 were plated in a volume of 50 uL in 96-well black-walled plates and incubated for 16-24 hours before addition of 100 uL viral supernatant to each well. Pseudovirus supernatants were diluted 1:10 in supplemented DMEM, followed by seven 2-fold serial dilutions. Each dilution was run in duplicate. Sixty hours after infection, 100 uL of media was removed from each well and 30 uL of Bright-Glo reagent (Promega) was added. Relative luciferase units (RLU) were then measured on a LUMIstar Omega plate reader.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.